Previous 10 | Next 10 |
WALTHAM, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, president and chief executive officer, will present at the Jefferies 2019 Global Healthcare Conference in New York City on Wednesday, June 5, 2019 at 3:00 p.m. EDT....
WALTHAM, Mass., May 17, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it will host an Analyst Day for the investment community on Wednesday, May 22, 2019 from 8:30 a.m. to 12:00 p.m. Eastern Time. Members of AMAG’s management team and key opi...
The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with their 2019 Q1 earnings Read more ...
AMAG Pharmaceuticals, Inc. (AMAG) Q1 2019 Earnings Conference Call May 07, 2019 08:00 AM ET Company Participants Linda Lennox - IR Bill Heiden - President and Chief Executive Officer Tony Casciano - Chief Commercial Officer Julie Krop - Chief Medical Officer Ted Myles - Chief...
AMAG Pharmaceuticals (NASDAQ: AMAG ): Q1 EPS of -$3.54 may not be comparable to consensus of -$0.31. More news on: AMAG Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Achieved record Feraheme revenue growth and more than 50% market share for Makena auto-injector Completed integration of Perosphere Pharmaceuticals Inc. and progressed ciraparantag clinical program Reaffirms 2019 financial guidance Conference call scheduled for 8:00 a.m. ET today ...
ADNT , AES , AGN , AKRX , AMAG , ARMK , ARRY , ATH , ATKR , AVNS , BCC , BGCP , BLD , BR , BUD , CJ , CLVS , CNHI , CNK , CRL , CROX , CTLT , CWEN , DEA , DF , DNR , DPLO , DXPE , EGRX , EMR , ENR , EXPD , FI , GSKY , GTE , GTX , HAE , HSIC , ICL , IM...
WALTHAM, Mass., May 03, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that it will present new data related to investigational drug bremelanotide for the treatment of hypoactive sexual desire disorder (HSDD) and Feraheme® (ferumoxytol) related to i...
WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its first quarter 2019 financial results will be released on Tuesday, May 7, 2019 before the U.S. financial markets open. Management will host a conference call and webcast at 8...
WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the Board of Directors of AMAG approved inducement awards to a new employee of (i) an option to purchase 15,000 shares of common stock and (ii) 7,500 restricted stock units. The ...
News, Short Squeeze, Breakout and More Instantly...
AMAG Pharmaceuticals Inc. Company Name:
AMAG Stock Symbol:
NASDAQ Market:
AMAG Pharmaceuticals Inc. Website:
WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal to withdraw approval for Makena—also referred to as 17-OHP...
MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&P SmallCap 600 MGIC Investment & Halozyme Therapeutics Set to Join S&P MidCap 400; First Bancorp, The Geo Group & Mednax to Join S&...
WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced today that it has formally requested a public hearing in response to the U.S. Food and Drug Administration’s (FDA) proposal to withdraw its approval of Makena ® , the only F...